Calithera Biosciences, Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for Calithera Biosciences, Inc. (CALA), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud · Insider-trading data from SEC EDGAR
Latest filing:
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Are CALA insiders buying or selling?
Calithera Biosciences, Inc. insiders reported no open-market purchases or sales in the last 12 months. Since October 2018, Trabud has recorded 23 Form 4 filings for CALA: 8 buys ($8.2M) and 15 sells ($14.0M).
Source: SEC EDGAR Form 4
Key Statistics (October 2018 – Feb 1, 2023)
Total Form 4 filings
23
SEC EDGAR
Insider filers
7
Insider buys (8)
$8.2M
Insider sells (15)
$14.0M
Insider sentiment
Net sellingNet insider flow of $5.7M in net selling since October 2018.
Recent CALA insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Feb 1, 2023 | Deepika Pakianathan | Director | Sale | 121.3K | $0.39 | $46.8K | SEC ↗ |
| Nov 12, 2021 | Keith Orford | Director | Sale | 78.2K | $0.87 | $68.1K | SEC ↗ |
| Nov 11, 2021 | Susan Molineaux | PRESIDENT & CEO | Purchase | 100.0K | $0.85 | $84.7K | SEC ↗ |
| Nov 11, 2021 | DRACHMAN JONATHAN G | Director | Purchase | 200.0K | $0.86 | $171.9K | SEC ↗ |
| Nov 11, 2021 | Christopher Molineaux | SR. VP, DEVELOPMENT | Purchase | 100.0K | $0.85 | $84.7K | SEC ↗ |
| Nov 10, 2021 | Keith Orford | Director | Sale | 51.8K | $0.84 | $43.5K | SEC ↗ |
| Dec 18, 2020 | Keith Orford | Chief Medical Officer | Sale | 2.4K | $6.00 | $14.7K | SEC ↗ |
| May 26, 2020 | BVF PARTNERS L P/IL | 10% Owner | Sale | 2.3M | $6.00 | $13.7M | SEC ↗ |
| Apr 17, 2020 | Stephanie Wong | SR. VP, FINANCE & SECRETARY | Sale | 5.0K | $8.00 | $40.0K | SEC ↗ |
| Feb 24, 2020 | Keith Orford | Chief Medical Officer | Sale | 3.0K | $8.00 | $24.2K | SEC ↗ |
| Dec 26, 2019 | Keith Orford | Chief Medical Officer | Sale | 3.0K | $6.00 | $18.1K | SEC ↗ |
| Nov 23, 2019 | BVF PARTNERS L P/IL | 10% Owner | Purchase | 192.0K | $3.91 | $750.8K | SEC ↗ |
| Nov 18, 2019 | BVF PARTNERS L P/IL | 10% Owner | Purchase | 128.5K | $3.37 | $433.0K | SEC ↗ |
| Oct 31, 2019 | BVF PARTNERS L P/IL | 10% Owner | Purchase | 2.4M | $2.63 | $6.3M | SEC ↗ |
| Jun 27, 2019 | Christopher Molineaux | SR. VP, DEVELOPMENT | Purchase | 51.6K | $3.88 | $200.2K | SEC ↗ |
| Jun 27, 2019 | Susan Molineaux | PRESIDENT AND CEO | Purchase | 51.6K | $3.88 | $200.2K | SEC ↗ |
| Jun 19, 2019 | Keith Orford | Chief Medical Officer | Sale | 417 | $6.00 | $2.5K | SEC ↗ |
| May 24, 2019 | Keith Orford | Chief Medical Officer | Sale | 416 | $6.00 | $2.5K | SEC ↗ |
| Apr 17, 2019 | Keith Orford | Chief Medical Officer | Sale | 416 | $6.33 | $2.6K | SEC ↗ |
| Mar 19, 2019 | Keith Orford | Chief Medical Officer | Sale | 417 | $6.43 | $2.7K | SEC ↗ |
| Mar 13, 2019 | Keith Orford | Chief Medical Officer | Sale | 1.6K | $6.00 | $9.4K | SEC ↗ |
| Oct 17, 2018 | Keith Orford | SR. VP, CLINICAL DEVELOPMENT | Sale | 313 | $6.05 | $1.9K | SEC ↗ |
| Oct 15, 2018 | Keith Orford | SR. VP, CLINICAL DEVELOPMENT | Sale | 1.3K | $6.00 | $7.5K | SEC ↗ |
Showing the 23 most recent of 23 Form 4 filings for Calithera Biosciences, Inc..
Most active CALA insiders
- Keith Orford12 filings
- BVF PARTNERS L P/IL4 filings
- Christopher Molineaux2 filings
- Susan Molineaux2 filings
- Deepika Pakianathan1 filing
Ask anything about CALA insider activity
Use Trabud's AI agent to query Calithera Biosciences, Inc.'s Form 4 history in plain English — "Show me CALA CEO purchases this year" or compare it against any other ticker.
Open the AI agentCALA insider trading FAQ
Are Calithera Biosciences, Inc. insiders buying or selling?
Calithera Biosciences, Inc. insiders reported no open-market purchases or sales in the last 12 months. Since October 2018, Trabud has recorded 23 Form 4 filings for CALA: 8 buys ($8.2M) and 15 sells ($14.0M). Over the full record that is net selling of $5.7M.
How many insiders trade CALA stock?
7 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Calithera Biosciences, Inc.. The most recent filing was accepted on Feb 1, 2023.
Where does Trabud get CALA insider trading data?
All CALA insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.